{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T06:27:46Z","timestamp":1786429666187,"version":"build-2736575974"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82361148722"],"award-info":[{"award-number":["82361148722"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2308600, 2024YFE0213800"],"award-info":[{"award-number":["2023YFC2308600, 2024YFE0213800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007847","name":"Natural Science Foundation of Jilin Province","doi-asserted-by":"publisher","award":["YDZJ202601ZYTS644"],"award-info":[{"award-number":["YDZJ202601ZYTS644"]}],"id":[{"id":"10.13039\/100007847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatocellular carcinoma (HCC) arises in the liver, an organ with active lipid metabolism, and is accompanied by marked myeloid-cell remodeling. Whether lipid-handling macrophage states are enriched in HCC and how they relate to candidate ligand\u2013receptor communication and tumor microenvironmental remodeling remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We analyzed paired tumor and adjacent liver single-cell transcriptomic data from 10 HCC patients. Tumor-associated lipid-handling candidates were screened using immune-cell composition, metabolic pathway activity, and tumor-upregulated lipid-related gene programs, with\n                      <jats:italic>APOE<\/jats:italic>\n                      prioritized for downstream analysis. Myeloid reclustering, module scoring, and CellChat analysis were used to characterize\n                      <jats:italic>APOE<\/jats:italic>\n                      -positive macrophages and infer\n                      <jats:italic>APOE<\/jats:italic>\n                      -positive macrophage-centered candidate communication. Hepa1\u20136 subcutaneous tumor models, an\n                      <jats:italic>Nras-Myc<\/jats:italic>\n                      -driven liver tumor model, mouse single-cell transcriptomics, and bone marrow-derived macrophage lipid-loading experiments were used to assess host\n                      <jats:italic>Apoe<\/jats:italic>\n                      deficiency, tumor-cell\n                      <jats:italic>Apoe<\/jats:italic>\n                      perturbation, and macrophage neutral lipid accumulation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      HCC tumors showed altered immune-cell composition and immune-metabolic pathway activity compared with adjacent liver tissues. Among tumor-upregulated lipid-related candidates,\n                      <jats:italic>APOE<\/jats:italic>\n                      was prioritized because of its tumor-associated expression, consistent ranking across lipid-related screening strategies, and functional relevance to lipoprotein and cholesterol handling.\n                      <jats:italic>APOE<\/jats:italic>\n                      -positive macrophages were enriched in tumors and displayed lipid-routing, cholesterol-handling, endolysosomal, and redox-adaptive programs. CellChat analysis identified candidate ligand\u2013receptor interactions involving\n                      <jats:italic>APOE<\/jats:italic>\n                      -positive macrophages, including an\n                      <jats:italic>APOE<\/jats:italic>\n                      \u2013\n                      <jats:italic>TREM2<\/jats:italic>\n                      -related incoming interaction and\n                      <jats:italic>SPP1<\/jats:italic>\n                      \u2013integrin\/\n                      <jats:italic>CD44<\/jats:italic>\n                      outgoing interactions. In the immunocompetent Hepa1\u20136 model, host\n                      <jats:italic>Apoe<\/jats:italic>\n                      deficiency attenuated tumor growth and was accompanied by reduced vascularization and increased CD8-positive cell infiltration, whereas tumor-cell\n                      <jats:italic>Apoe<\/jats:italic>\n                      knockdown did not significantly affect tumor volume or tumor weight in immunodeficient mice. In the\n                      <jats:italic>Nras-Myc<\/jats:italic>\n                      liver tumor model,\n                      <jats:italic>Apoe<\/jats:italic>\n                      deficiency reduced tumor burden and proliferative activity and was accompanied by a shift in tumor macrophage and monocyte programs away from lipid-processing and phagolysosomal activity toward inflammatory chemokine-associated activity. In lipid-loaded bone marrow-derived macrophages,\n                      <jats:italic>Apoe<\/jats:italic>\n                      deficiency increased neutral lipid accumulation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This study links\n                      <jats:italic>APOE<\/jats:italic>\n                      -associated macrophage lipid handling to inferred ligand\u2013receptor communication and host\n                      <jats:italic>Apoe<\/jats:italic>\n                      -linked microenvironmental remodeling in HCC. These findings highlight an\n                      <jats:italic>APOE<\/jats:italic>\n                      -linked myeloid lipid-handling program as a potential component of immune microenvironmental remodeling during HCC development.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1902143","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T05:35:08Z","timestamp":1786426508000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["APOE-associated lipid-handling macrophages in hepatocellular carcinoma: ligand\u2013receptor communication and host Apoe-linked myeloid remodeling"],"prefix":"10.3389","volume":"17","author":[{"given":"Tong","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Hepatology, Center of Infectious Diseases and Pathogen Biology, The First Hospital of Jilin University","place":["Changchun, China"]},{"name":"Jilin Provincial Key Laboratory of Metabolic Liver Diseases, The First Hospital of Jilin University, Jilin University","place":["Changchun, China"]},{"name":"China\u2013Singapore Belt and Road Joint Laboratory on Liver Disease Research, The First Hospital of Jilin University, Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guijie","family":"Xin","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Center of Infectious Diseases and Pathogen Biology, The First Hospital of Jilin University","place":["Changchun, China"]},{"name":"Jilin Provincial Key Laboratory of Metabolic Liver Diseases, The First Hospital of Jilin University, Jilin University","place":["Changchun, China"]},{"name":"China\u2013Singapore Belt and Road Joint Laboratory on Liver Disease Research, The First Hospital of Jilin University, Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Center of Infectious Diseases and Pathogen Biology, The First Hospital of Jilin University","place":["Changchun, China"]},{"name":"Jilin Provincial Key Laboratory of Metabolic Liver Diseases, The First Hospital of Jilin University, Jilin University","place":["Changchun, China"]},{"name":"China\u2013Singapore Belt and Road Joint Laboratory on Liver Disease Research, The First Hospital of Jilin University, Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Center of Infectious Diseases and Pathogen Biology, The First Hospital of Jilin University","place":["Changchun, China"]},{"name":"Jilin Provincial Key Laboratory of Metabolic Liver Diseases, The First Hospital of Jilin University, Jilin University","place":["Changchun, China"]},{"name":"China\u2013Singapore Belt and Road Joint Laboratory on Liver Disease Research, The First Hospital of Jilin University, Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqi","family":"Niu","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Center of Infectious Diseases and Pathogen Biology, The First Hospital of Jilin University","place":["Changchun, China"]},{"name":"Jilin Provincial Key Laboratory of Metabolic Liver Diseases, The First Hospital of Jilin University, Jilin University","place":["Changchun, China"]},{"name":"China\u2013Singapore Belt and Road Joint Laboratory on Liver Disease Research, The First Hospital of Jilin University, Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"Ca: A Cancer J For Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0044-z","article-title":"The immunology of hepatocellular carcinoma","volume":"19","author":"Ringelhan","year":"2018","journal-title":"Nat Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217007","article-title":"PDP1 promotes KRAS mutant colorectal cancer progression by serving as a scaffold for BRAF and MEK1","volume":"597","author":"Yuan","year":"2024","journal-title":"Cancer Lett"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70267","article-title":"MTHFD1 regulates autophagy to promote growth and metastasis in colorectal cancer via the PI3K-AKT-mTOR signaling pathway","volume":"13","author":"Li","year":"2024","journal-title":"Cancer Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus Bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00383-9","article-title":"The immunological and metabolic landscape in primary and metastatic liver cancer","volume":"21","author":"Li","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00541-y","article-title":"Metabolic barriers to cancer immunotherapy","volume":"21","author":"DePeaux","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0127-6","article-title":"Macrophages as regulators of tumour immunity and immunotherapy","volume":"19","author":"DeNardo","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nrd.2018.169","article-title":"Targeting macrophages: therapeutic approaches in cancer","volume":"17","author":"Cassetta","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.10.003","article-title":"Landscape and dynamics of single immune cells in hepatocellular carcinoma","volume":"179","author":"Zhang","year":"2019","journal-title":"Cell"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2019.08.007","article-title":"Tumor cell biodiversity drives microenvironmental reprogramming in liver cancer","volume":"36","author":"Ma","year":"2019","journal-title":"Cancer Cell"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.11.041","article-title":"Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma","volume":"184","author":"Sun","year":"2021","journal-title":"Cell"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05400-x","article-title":"Liver tumour immune microenvironment subtypes and neutrophil heterogeneity","volume":"612","author":"Xue","year":"2022","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/egastro-2025-100189","article-title":"Characterisation of macrophages in healthy and diseased livers in mice: identification of necrotic lesion-associated macrophages","volume":"3","author":"Feng","year":"2025","journal-title":"eGastroenterology"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.05.054","article-title":"Lipid-associated macrophages control metabolic homeostasis in a Trem2-dependent manner","volume":"178","author":"Jaitin","year":"2019","journal-title":"Cell"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000001098","article-title":"TREM2 macrophages mediate the beneficial effects of bariatric surgery against MASH","volume":"81","author":"Fredrickson","year":"2025","journal-title":"Hepatol (Baltimore Md)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"6770","DOI":"10.1038\/s41467-025-62132-y","article-title":"Metabolism archetype cancer cells induce protumor TREM2(+) macrophages via oxLDL-mediated metabolic interplay in hepatocellular carcinoma","volume":"16","author":"Chu","year":"2025","journal-title":"Nat Commun"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/iub.1314","article-title":"Apolipoprotein E isoforms and lipoprotein metabolism","volume":"66","author":"Phillips","year":"2014","journal-title":"IUBMB Life"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1886","article-title":"The rs429358 locus in apolipoprotein E is associated with hepatocellular carcinoma in patients with cirrhosis","volume":"6","author":"Innes","year":"2022","journal-title":"Hepatol Commun"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2025.101485","article-title":"Genome-wide meta-analysis identifies nine loci associated with higher risk of hepatocellular carcinoma development","volume":"7","author":"Ghouse","year":"2025","journal-title":"Jhep Rep Innovation Hepatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13059-020-1950-6","article-title":"Decontamination of ambient RNA in single-cell RNA-seq with DecontX","volume":"21","author":"Yang","year":"2020","journal-title":"Genome Biol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive integration of single-cell data","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat Methods"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-0316","article-title":"Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level","volume":"12","author":"Wu","year":"2022","journal-title":"Cancer Discov"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr988","article-title":"KEGG for integration and interpretation of large-scale molecular data sets","volume":"40","author":"Kanehisa","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.4463","article-title":"SCENIC: single-cell regulatory network inference and clustering","volume":"14","author":"Aibar","year":"2017","journal-title":"Nat Methods"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The Gene Ontology Consortium","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat Genet"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkad1025","article-title":"The reactome pathway knowledgebase 2024","volume":"52","author":"Milacic","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat Commun"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods (San Diego Calif)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"key":"B35","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Ser B Stat Method"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202504436","article-title":"Exosomal CMTM4 induces immunosuppressive macrophages to promote ovarian cancer progression and attenuate anti-PD-1 immunotherapy","volume":"12","author":"Yin","year":"2025","journal-title":"Advanced Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1621816","article-title":"Oncogenic CMTM6 drives M2a macrophages formation and fuels cervical cancer progression","volume":"16","author":"Yin","year":"2025","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1709597","article-title":"SLC40A1-mediated positive feedback loop with M1 macrophages suppresses epithelial ovarian cancer progression","volume":"16","author":"Wang","year":"2026","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.08.008","article-title":"The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases","volume":"47","author":"Krasemann","year":"2017","journal-title":"Immunity"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00837-1","article-title":"The biology of TREM receptors","volume":"23","author":"Colonna","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","article-title":"A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells","volume":"184","author":"Cheng","year":"2021","journal-title":"Cell"},{"key":"B42","doi-asserted-by":"publisher","first-page":"5665","DOI":"10.1038\/s41467-024-49885-8","article-title":"Using a pan-cancer atlas to investigate tumour associated macrophages as regulators of immunotherapy response","volume":"15","author":"Coulton","year":"2024","journal-title":"Nat Commun"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.679043","article-title":"Apolipoprotein E is a ligand for triggering receptor expressed on myeloid cells 2 (TREM2)","volume":"290","author":"Atagi","year":"2015","journal-title":"J Biol Chem"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1902143\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T05:35:10Z","timestamp":1786426510000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1902143\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":43,"alternative-id":["10.3389\/fimmu.2026.1902143"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1902143","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"article-number":"1902143"}}